Stock A284620 KAINOS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kainos Medicine, Inc.

Equities

A284620

KR7284620002

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2,895 KRW -5.08% Intraday chart for Kainos Medicine, Inc. +7.02% -32.99%
2023 Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index CI
2022 Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. CI

Business Summary

Kainos Medicine Inc is a Korea-based company mainly engaged in the research and development of pharmaceuticals. The Company is engaged in the research and development of degenerative brain disease treatments, antiviral drugs, anticancer drugs and other products. In addition, the Company is engaged in the research and development of Parkinson's disease drugs, AIDS drugs, blood anticancer drugs and other products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Royalty
100.0 %
130 100.0 % 267 100.0 % +105.59%

Sales per region

KRW in Million2022Weight2023Weight Delta
China
100.0 %
130 100.0 % 267 100.0 % +105.59%

Managers

Managers TitleAgeSince
Ki-Sub Lee CEO
 Chief Executive Officer 73 07-06-14
Jae-Moon Lee PSD
 President 66 -
In-Chul Kim PRN
 Corporate Officer/Principal 73 -
Chi-Yong Noh AUD
 Comptroller/Controller/Auditor 71 -

Members of the board

Members of the board TitleAgeSince
Ki-Sub Lee CEO
 Chief Executive Officer 73 07-06-14
Jae-Moon Lee PSD
 President 66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 27,922,396 24,451,041 ( 87.57 %) 5,585 ( 0.0200 %) 87.57 %

Shareholders

NameEquities%Valuation
Ki-Sub Lee
11.30 %
3,154,528 11.30 % 8 M ₩
In-seok Choi
4.215 %
1,176,956 4.215 % 3 M ₩
Ae-ju Lee
3.895 %
1,087,450 3.895 % 3 M ₩
Gun-hwan Lee
1.981 %
553,063 1.981 % 1 M ₩
Mi-ran Noh
0.2489 %
69,486 0.2489 % 187 102 ₩
Mi-sook Noh
0.2449 %
68,380 0.2449 % 184 124 ₩
Byung-Jae Kim
0.1289 %
36,000 0.1289 % 96 936 ₩
Briana Lee
0.1087 %
30,345 0.1087 % 81 709 ₩
Miriam Lee
0.1086 %
30,336 0.1086 % 81 685 ₩
Kwang-ho Lee
0.0791 %
22,080 0.0791 % 59 454 ₩

Holdings

NameEquities%Valuation
KAINOS MEDICINE, INC.
0.02%
 5,585 0.02% 15,039 $

Company contact information

Kainos Medicine, Inc.

3rd Floor, Building A 700 Daewangpangyo-ro

13488, Seongnam-si

+

http://www.kainosmedicine.com
address Kainos Medicine, Inc.(A284620)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
KAINOS MEDICINE, INC. Stock Kainos Medicine, Inc.
-32.99% 58.73M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A284620 Stock
  4. Company Kainos Medicine, Inc.